These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2629098)

  • 1. Magnetic resonance microscopy of chemically-induced liver foci.
    Johnson GA; Maronpot RR
    Toxicol Pathol; 1989; 17(4 Pt 1):613-6. PubMed ID: 2629098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection.
    Williams GM
    Toxicol Pathol; 1989; 17(4 Pt 1):663-72; discussion 673-4. PubMed ID: 2697941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats.
    Harada T; Maronpot RR; Morris RW; Stitzel KA; Boorman GA
    Toxicol Pathol; 1989; 17(4 Pt 1):579-93. PubMed ID: 2483465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining foci of cellular alteration in short-term and medium-term rat liver tumor models.
    Popp JA; Goldsworthy TL
    Toxicol Pathol; 1989; 17(4 Pt 1):561-8. PubMed ID: 2697937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and grading of rat liver foci in carcinogenicity tests.
    Squire RA
    Toxicol Pathol; 1989; 17(4 Pt 1):685-8; discussion 688-9. PubMed ID: 2697943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on altered hepatocellular foci in National Toxicology Program two-year carcinogenicity studies in rats.
    Harada T; Maronpot RR; Morris RW; Boorman GA
    Toxicol Pathol; 1989; 17(4 Pt 1):690-706; discussion 707-8. PubMed ID: 2629101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological implications of rat liver foci and relevance to regulatory decision-making: current status and future perspective.
    Hayashi Y
    Toxicol Pathol; 1989; 17(4 Pt 1):716-20. PubMed ID: 2629103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of hepatic neoplasms in the rat.
    Johnson GA; Thompson MB; Cofer GP; Campen D; Maronpot RR
    Vet Pathol; 1989 Jul; 26(4):303-8. PubMed ID: 2763419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-term carcinogenicity bioassay.
    Della Porta G
    Jpn J Cancer Res; 1992 Aug; 83(8):inside front cover. PubMed ID: 1399815
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular foci--a regulator's Gordian.
    Moch RW; O'Neill TP
    Toxicol Pathol; 1989; 17(4 Pt 1):724-8. PubMed ID: 2629105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hepatic foci in rat liver as weight of evidence of carcinogenicity: the Canadian perspective.
    Mahon DC
    Toxicol Pathol; 1989; 17(4 Pt 1):709-15. PubMed ID: 2629102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of foci of cellular alteration in the rat liver. A symposium. Research Triangle Park, North Carolina, May 22-23, 1989. Proceedings.
    Toxicol Pathol; 1989; 17(4 Pt 1):557-735. PubMed ID: 2629097
    [No Abstract]   [Full Text] [Related]  

  • 13. Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: current practices of the National Toxicology Program.
    Maronpot RR; Harada T; Murthy AS; Boorman GA
    Toxicol Pathol; 1989; 17(4 Pt 1):675-83; discussion 683-4. PubMed ID: 2697942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing statistical hypotheses about rat liver foci.
    Morris RW
    Toxicol Pathol; 1989; 17(4 Pt 1):569-78. PubMed ID: 2697938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging.
    Kawamori Y; Matsui O; Kadoya M; Yoshikawa J; Demachi H; Takashima T
    Radiology; 1992 Apr; 183(1):65-72. PubMed ID: 1549696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rat liver altered focus models for testing chemicals that have completed two-year carcinogenicity studies.
    Maronpot RR; Pitot HC; Peraino C
    Toxicol Pathol; 1989; 17(4 Pt 1):651-62. PubMed ID: 2629100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver tumor promoting effects of fenbendazole in rats.
    Shoda T; Onodera H; Takeda M; Uneyama C; Imazawa T; Takegawa K; Yasuhara K; Watanabe T; Hirose M; Mitsumori K
    Toxicol Pathol; 1999; 27(5):553-62. PubMed ID: 10528635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profound postinitiation enhancement by short-term severe methionine, choline, vitamin B12, and folate deficiency of hepatocarcinogenesis in F344 rats given a single low-dose diethylnitrosamine injection.
    Hoover KL; Lynch PH; Poirier LA
    J Natl Cancer Inst; 1984 Dec; 73(6):1327-36. PubMed ID: 6595443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
    Ohshima M; Ward JM; Brennan LM; Creasia DA
    J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.